Walleye Capital
ACHN

Walleye Capital’s Achillion Pharmaceuticals ACHN Stock Holding History

Walleye Capital’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-278,205
Closed -$1.68M – 2042
2019
Q4 		$1.68M Buy
+278,205
New +$1.61M 0.11% 255

Walleye Capital's ACHN Position: Q1 2020 in Review

Walleye Capital sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 278,205 shares — an estimated $1.68M sold.

Walleye Capital first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $1.68M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Walleye Capital reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Walleye Capital sold 278,205 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.68M.
  • Walleye Capital first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Walleye Capital's Achillion Pharmaceuticals position peaked at $1.68M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.